GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human TLR8 in complex with cu-CPT9A

Analyse Crystal structure of human TLR8 in complex with cu-CPT9A in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5Z14
Type
protein
Length
1,477 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Toll-like receptor 8
UniProt
Q9NR97
Ligands
7VC, NAG, MAN, BMA
Pockets
15 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 10% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AToll-like receptor 8protein74310% helix, 17% strandQ9NR97
BToll-like receptor 8protein73410% helix, 17% strandQ9NR97

Ligands and binding sites

  • 7VC · 4-(7-methoxyquinolin-4-yl)-2-methyl-phenol · ligand · 2 copies · chains A, B
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 15 copies · chains A, B
  • MAN · alpha-D-mannopyranose · sugar · 5 copies · chains B
  • BMA · beta-D-mannopyranose · sugar · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 9 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18810.810.831157VC
25870.700.7866empty
31250.700.90277VC
42280.640.8229NAG
53190.620.7942NAG

Interfaces

1 interface between chains.

  • A–B · 1709 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 disulfide, 9 glycan (disulfide, N-glycosylation).

Compared structures

  • 5Z14 · Crystal structure of human TLR8 in complex with CU-CPT9a · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.